| Full Name | Matthew Vargas |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 300 Trade Center, Woburn, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013693936 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Proex Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1831190453 PECOS PAC ID: 0345212395 Enrollment ID: O20040810000744 |
News Archive
There are thousands of children's toy manufacturers around the world. Toys can be made of metal, plastic, paint, fabric and many other components, but are they really safe for your children.
VCU Massey Cancer Center physician-researcher Charles E. Geyer, Jr., M.D., was the National Protocol Officer for one component of a large national study involving two National Cancer Institute-supported clinical trials that demonstrated that trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients.
In two new papers in The Lancet that report dramatic worldwide increases in body-mass index (BMI) and type 2 diabetes, the U.S. territory of American Samoa and independent Samoa are mentioned for their especially high prevalence of both conditions.
Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer, today announced a US$8.8M Series A financing round with leading international healthcare investors Canaan and Australia's Medical Research Commercialization Fund managed by Brandon Capital.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Vargas, 576 Broadhollow Rd, Melville, NY 11747 Ph: (631) 359-5800 | Matthew Vargas, 300 Trade Center, Woburn, MA 01801 Ph: (781) 925-7643 |
News Archive
There are thousands of children's toy manufacturers around the world. Toys can be made of metal, plastic, paint, fabric and many other components, but are they really safe for your children.
VCU Massey Cancer Center physician-researcher Charles E. Geyer, Jr., M.D., was the National Protocol Officer for one component of a large national study involving two National Cancer Institute-supported clinical trials that demonstrated that trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients.
In two new papers in The Lancet that report dramatic worldwide increases in body-mass index (BMI) and type 2 diabetes, the U.S. territory of American Samoa and independent Samoa are mentioned for their especially high prevalence of both conditions.
Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer, today announced a US$8.8M Series A financing round with leading international healthcare investors Canaan and Australia's Medical Research Commercialization Fund managed by Brandon Capital.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
› Verified 8 days ago
Selina Fay, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Tradecenter, Woburn, MA 01801 Phone: 781-937-9777 | |
Scott E Havemeyer, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 150 Presidential Way, Suite 110, Woburn, MA 01801 Phone: 781-782-1300 Fax: 781-782-1350 | |
Jeffrey Stalker, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 200 Unicorn Park Dr Ste 201, Woburn, MA 01801 Phone: 781-782-1300 Fax: 781-782-1350 | |
Miss Lindsey Marie Wolfe, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 444 Washington St Ste 401, Woburn, MA 01801 Phone: 781-937-9777 | |
Kimberly Sarnacki, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 W Cummings Park, Woburn, MA 01801 Phone: 781-933-8800 | |
Jenkyns Physical Therapy & Wellness Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 W Cummings Park, Suite 4650, Woburn, MA 01801 Phone: 339-298-2084 Fax: 339-298-2085 |